Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,724,715
  • Shares Outstanding, K 51,624
  • Annual Sales, $ 190,410 K
  • Annual Income, $ 20,890 K
  • EBIT $ 9 M
  • EBITDA $ 11 M
  • 60-Month Beta -2.81
  • Price/Sales 14.25
  • Price/Cash Flow 123.07
  • Price/Book 6.27

Options Overview Details

View History
  • Implied Volatility 15.20% (-1.94%)
  • Historical Volatility 100.20%
  • IV Percentile 1%
  • IV Rank 0.74%
  • IV High 124.05% on 10/20/25
  • IV Low 14.40% on 04/10/26
  • Expected Move (DTE 27) 0.09 (0.16%)
  • Put/Call Vol Ratio 0.36
  • Today's Volume 6,821
  • Volume Avg (30-Day) 8,821
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 154,601
  • Open Int (30-Day) 82,226
  • Expected Range 52.70 to 52.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.73
  • Number of Estimates 6
  • High Estimate $0.93
  • Low Estimate $0.62
  • Prior Year $-0.95
  • Growth Rate Est. (year over year) +176.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.43 +79.34%
on 03/27/26
52.80 -0.04%
on 04/17/26
+19.16 (+56.99%)
since 03/17/26
3-Month
29.43 +79.34%
on 03/27/26
52.80 -0.04%
on 04/17/26
+10.30 (+24.25%)
since 01/16/26
52-Week
29.43 +79.34%
on 03/27/26
90.32 -41.56%
on 07/09/25
-17.20 (-24.58%)
since 04/17/25

Most Recent Stories

More News
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO

NEW ORLEANS , April 17, 2026 /PRNewswire/ -- ClaimsFiler , a FREE shareholder information service, reminds investors that they have until May 5, 2026  to file lead plaintiff applications...

SLNO : 52.78 (+0.40%)
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK , April 17, 2026 /PRNewswire/ --

SLNO : 52.78 (+0.40%)
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , April 17, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

SLNO : 52.78 (+0.40%)
SLNO SHAREHOLDER NOTICE: Hagens Berman Alerts Soleno (SLNO) Investors to Pending Securities Fraud Class Action and Upcoming May 5th Lead Plaintiff Deadline

SAN FRANCISCO , April 17, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class...

SLNO : 52.78 (+0.40%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SLNO

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO).   Such...

SLNO : 52.78 (+0.40%)
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

SLNO : 52.78 (+0.40%)
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt

Key Dates and Disclosure Events Shareholders Need to Know

SLNO : 52.78 (+0.40%)
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , April 15, 2026 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that investors with losses related to Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:...

SLNO : 52.78 (+0.40%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--FORA, SLNO, MKC, and OMEX

NEW YORK , April 15, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

OMEX : 1.0600 (-4.50%)
MKC : 54.33 (+1.99%)
FORA : 2.15 (-0.46%)
SLNO : 52.78 (+0.40%)
INVESTOR DEADLINE: Soleno Therapeutics, Inc. (SLNO) Investors with Substantial Losses Have Opportunity to Lead the Soleno Class Action Lawsuit- Hagens Berman

SAN FRANCISCO , April 15, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class...

SLNO : 52.78 (+0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 53.07
2nd Resistance Point 52.93
1st Resistance Point 52.86
Last Price 52.78
1st Support Level 52.65
2nd Support Level 52.51
3rd Support Level 52.44

See More

52-Week High 90.32
Fibonacci 61.8% 67.06
Fibonacci 50% 59.87
Last Price 52.78
Fibonacci 38.2% 52.69
52-Week Low 29.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.